Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017

Επιστημονική δημοσίευση - Άρθρο Περιοδικού
uoadl:3000315

Μονάδες

Ερευνητικό υλικό ΕΚΠΑ

Τίτλος

Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors...

Περισσότερα

Γλώσσες Τεκμηρίου

Αγγλικά

Περίληψη

Background Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980-2017 and forecast these estimates to 2030 for 195 countries and territories. Methods We determined a modelling strategy for each country on the basis of the availability and quality of data. For countries and territories with data from population-based seroprevalence surveys or antenatal care clinics, we estimated prevalence and incidence using an open-source version of the Estimation and Projection Package - a natural history model originally developed by the UNAIDS Reference Group on Estimates, Modelling, and Projections. For countries with cause-specific vital registration data, we corrected data for garbage coding (ie, deaths coded to an intermediate, immediate, or poorly defined cause) and HIV misclassification. We developed a process of cohort incidence bias adjustment to use information on survival and deaths recorded in vital registration to back-calculate HIV incidence. For countries without any representative data on HIV, we produced incidence estimates by pulling information from observed bias in the geographical region. We used a re-coded version of the Spectrum model (a cohort component model that uses rates of disease progression and HIV mortality on and off ART) to produce agesex- specific incidence, prevalence, and mortality, and treatment coverage results for all countries, and forecast these measures to 2030 using Spectrum with inputs that were extended on the basis of past trends in treatment scale-up and new infections. Findings Global HIV mortality peaked in 2006 with 1·95 million deaths (95% uncertainty interval 1·87-2·04) and has since decreased to 0·95 million deaths (0·91-1·01) in 2017. New cases of HIV globally peaked in 1999 (3·16 million, 2·79-3·67) and since then have gradually decreased to 1·94 million (1·63-2·29) in 2017. These trends, along with ART scale-up, have globally resulted in increased prevalence, with 36·8 million (34·8-39·2) people living with HIV in 2017. Prevalence of HIV was highest in southern sub-Saharan Africa in 2017, and countries in the region had ART coverage ranging from 65·7% in Lesotho to 85·7% in eSwatini. Our forecasts showed that 54 countries will meet the UNAIDS target of 81% ART coverage by 2020 and 12 countries are on track to meet 90% ART coverage by 2030. Forecasted results estimate that few countries will meet the UNAIDS 2020 and 2030 mortality and incidence targets. Interpretation Despite progress in reducing HIV-related mortality over the past decade, slow decreases in incidence, combined with the current context of stagnated funding for related interventions, mean that many countries are not on track to reach the 2020 and 2030 global targets for reduction in incidence and mortality. With a growing population of people living with HIV, it will continue to be a major threat to public health for years to come. The pace of progress needs to be hastened by continuing to expand access to ART and increasing investments in proven HIV prevention initiatives that can be scaled up to have population-level impact. © 2019 The Author(s).

Έτος δημοσίευσης

2019

Συγγραφείς

Frank, T.D. Carter, A. Jahagirdar, D. Biehl, M.H. Douwes-Schultz, D. Larson, S.L. Arora, M. Dwyer-Lindgren, L. Steuben, K.M. Abbastabar, H. Abu-Raddad, L.J. Abyu, D.M. Adabi, M. Adebayo, O.M. Adekanmbi, V. Adetokunboh,...

Περισσότερα

Περιοδικό

null

Εκδότης

Elsevier Ireland Ltd

Τόμος

6

Αριθμός / τεύχος

12

Σελίδες

e831-e859

Λέξεις-κλειδιά

anti human immunodeficiency virus agent
adolescent
adult
Afghanistan
Africa south of the Sahara
aged
Albania
Algeria
Andorra
Angola
antiretroviral therapy
Argentina
Armenia
Article
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
cause specific survival
Chad
child
Chile
China
Colombia
Comoros
Congo
Costa Rica
Cote d'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
disease exacerbation
disease registry
Djibouti
Dominica
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Federated States of Micronesia
female
Fiji
Finland
forecasting
France
Gabon
Gambia
Georgia (republic)
Germany
Ghana
global disease burden
Greece
Greenland
Grenada
groups by age
Guam
Guatemala
Guinea-Bissau
Guyana
Haiti
Honduras
human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
Human immunodeficiency virus prevalence
Hungary
Iceland
incidence
India
Indonesia
infant
infection risk
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Lithuania
Luxembourg
Macedonia (republic)
Madagascar
major clinical study
Malawi
Malaysia
Maldives
male
Mali
Malta
Mauritania
Mauritius
Mexico
middle aged
model
Moldova
Mongolia
Montenegro (republic)
Morocco
mortality
Mozambique
Myanmar
Namibia
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
North Korea
Norway
Oman
Pacific islands
Pakistan
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
prenatal care
preschool child
priority journal
Puerto Rico
Qatar
Romania
Russian Federation
Rwanda
Saint Lucia
Saint Vincent and the Grenadines
Sao Tome and Principe
Saudi Arabia
school child
Senegal
Serbia
seroprevalence
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tonga
Tunisia
Turkey (republic)
Turkmenistan
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
very elderly
Viet Nam
Yemen
young adult
Zambia
Zimbabwe
cause of death
forecasting
global disease burden
history
Human immunodeficiency virus infection
incidence
prevalence
risk factor
seroepidemiology
Cause of Death
Forecasting
Global Burden of Disease
History
20th Century
History
21st Century
HIV Infections
Humans
Incidence
Prevalence
Risk Factors
Seroepidemiologic Studies

Τελευταία τροποποίηση

πριν από 3 έτη

Άδεια χρήσης

Creative Commons Αναφορά Δημιουργού-Μη Εμπορική Χρήση 4.0 (CC-BY-NC)

Εξαγωγή Citation

Ο ιστοχώρος χρησιμοποιεί cookies για να σας προσφέρει πιο πλούσια εμπειρία χρήσης. Εφόσον συνεχίσετε να τον χρησιμοποιείτε, αποδέχεστε και τη χρήση των cookies. Περισσότερες πληροφορίες: https://www.uoa.gr/to_panepistimio/prostasia_prosopikon_dedomenon/